GM1 Gangliosidosis Type II: Sub-classification of late infantile and juvenile patients based on age at symptom onset

被引：0
|
作者：
Regier, Debra S. [1 ]
Golas, Gretchen [1 ]
Johnston, Jean [1 ]
Tifft, Cynthia J. [1 ]
机构：
[1] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2015年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [41] Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene
    Karimzadeh, Parvaneh
    Naderi, Samaneh
    Modarresi, Farzaneh
    Dastsooz, Hassan
    Nemati, Hamid
    Farokhashtiani, Tayebeh
    Shamsian, Bibi Shahin
    Inaloo, Soroor
    Faghihi, Mohammad Ali
    BMC MEDICAL GENETICS, 2017, 18
  • [42] Updated interim safety, biomarker, and efficacy data from Imagine-1: A phase 1/2 open-label, multicenter study to assess the safety, tolerability, and efficacy of a single dose, intra-cisterna magna (ICM) administration of PBGM01 in subjects with type I (early onset) and type IIA (late onset) infantile GM1 gangliosidosis (GM1)
    Jarnes, Jeanine R.
    Hastings, Caroline A.
    Ficicioglu, Can H.
    Day-Salvatore, Debra-Lynn
    Giugliani, Roberto
    Baruteau, Julien
    Whitley, Chester B.
    Inbar-Feigenberg, Michal
    Bernard, Genevieve
    Ezgu, Fatih S.
    Ni, Yan G.
    Miller, Michelle
    Gelb, Michael H.
    Nagilla, Pruthvi
    Johnstone, Rose
    Elsasser, Patricia
    Cunningham, Elizabeth
    Ballard, Victoria
    Haws, Thomas F.
    Forman, Mark S.
    Weinstein, David A.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 68 - 68
  • [43] Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience
    Fischetto, Rita
    Palladino, Valentina
    Mancardi, Maria M.
    Giacomini, Thea
    Palladino, Stefano
    Gaeta, Alberto
    Di Rocco, Maja
    Zampini, Lucia
    Lassandro, Giuseppe
    Favia, Vito
    Tripaldi, Maria E.
    Strisciuglio, Pietro
    Romano, Alfonso
    Severino, Mariasavina
    Morrone, Amelia
    Giordano, Paola
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (10):
  • [44] Safety and preliminary efficacy of LYS-GM101 gene therapy in patients with GM1 gangliosidosis: Results of a phase I/II openlabel clinical trial
    Ghosh, Arunabha
    Heron, Benedicte
    Donald, Aimee
    Chang, Harriet
    Furness, Laura
    Movsesyan, Nina
    Ravelli, Claudia
    Jones, Simon
    Wang, Raymond Y.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [45] Targeting GLB1 in mice by CRISPR/Cas9 genome editing: Establishing a novel model for type II GM1 gangliosidosis
    Nicoli, Elena-Raluca
    Han, Ted
    Yoon, Robin
    Glase, Brianna
    Latour, Yvonne
    Huebecker, Mylene
    D'Souza, Andrea
    Peiravi, Morteza
    Tyrlik, Michal
    Springer, Danielle
    Jeeva, Jeeva Munasinghe
    Donahue, Danielle
    Sidhu, Rohini
    Kell, Pamela
    Jiang, Xuntian
    Acosta, Maria
    Platt, Frances M.
    Proia, Richard L.
    Tifft, Cynthia J.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S116 - S116
  • [46] AXO-AAV-GM2 Gene Therapy for Infantile- and Juvenile-onset GM2 Gangliosidosis: Preliminary Results from an Ongoing Phase 1/2 Trial
    Eichler, Florian
    Flotte, Terence
    Andonian, Haley
    Cataltepe, Oguz
    Artinian, Rebecca
    Misko, Albert
    Thorp, Benjamin
    Jameson, John
    Sheehan, Michael
    Vaughn, Toby
    Valencia, Donna
    De Boever, Erika
    MOLECULAR THERAPY, 2022, 30 (05) : 6 - 7
  • [47] Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased 1H NMR-Linked Metabolomics Strategy
    Percival, Benita C.
    Latour, Yvonne L.
    Tifft, Cynthia J.
    Grootveld, Martin
    CELLS, 2021, 10 (03) : 1 - 52
  • [48] The MorquioBetter Project: Global patient registry for Morquio syndrome type B disease and late-onset GM1-gangliosidosis
    Alexander, George
    van Karnebeek, Clara
    Stockler-Ipsiroglu, Sylvia
    Paschke, Eduard
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S18 - S19
  • [49] Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient
    Anna Caciotti
    Tiziana Bardelli
    John Cunningham
    Alessandra D'Azzo
    Enrico Zammarchi
    Amelia Morrone
    Human Genetics, 2003, 113 : 44 - 50
  • [50] PRESENCE OF GLYCOPROTEINS CONTAINING THE POLYLACTOSAMINE STRUCTURE IN BRAIN AND LIVER OF GM1 GANGLIOSIDOSIS PATIENTS - COMPARATIVE-STUDY BETWEEN CLINICAL TYPE-I AND TYPE-II, USING ENDO-BETA-GALACTOSIDASE ENZYME
    BERRA, B
    DEGASPERI, R
    RAPELLI, S
    OKADA, S
    LI, SC
    LI, YT
    NEUROCHEMICAL PATHOLOGY, 1986, 4 (02): : 107 - 117
12345